Asthika Goonewardene
Stock Analyst at Truist Securities
(1.42)
# 2,515
Out of 4,479 analysts
70
Total ratings
37.68%
Success rate
-11.06%
Average return
Main Sectors:
Top Industries:
20 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RCUS Arcus Biosciences | Maintains: Buy | $50 → $44 | $14.65 | +200.34% | 1 | Jun 24, 2024 | |
| ACLX Arcellx | Maintains: Buy | $87 | $53.25 | +63.38% | 4 | Jun 18, 2024 | |
| LEGN Legend Biotech | Initiates: Buy | $88 | $44.74 | +96.69% | 1 | Jun 17, 2024 | |
| GMAB Genmab | Maintains: Buy | $50 → $53 | $24.90 | +112.85% | 10 | Jun 4, 2024 | |
| MRUS Merus | Maintains: Buy | $69 → $88 | $53.09 | +65.76% | 2 | Jun 4, 2024 | |
| CGEN Compugen | Maintains: Buy | $5 → $4 | $1.69 | +136.69% | 5 | May 21, 2024 | |
| CRBU Caribou Biosciences | Maintains: Buy | $19 | $1.60 | +1,087.50% | 3 | May 16, 2024 | |
| CRGX CARGO Therapeutics | Reiterates: Buy | $34 → $32 | $15.83 | +102.15% | 2 | May 16, 2024 | |
| ALLO Allogene Therapeutics | Maintains: Buy | $17 | $2.16 | +687.04% | 4 | May 15, 2024 | |
| STRO Sutro Biopharma | Maintains: Buy | $25 → $18 | $2.96 | +508.11% | 5 | Apr 3, 2024 | |
| IOVA Iovance Biotherapeutics | Maintains: Buy | $17 → $26 | $7.73 | +236.35% | 5 | Mar 7, 2024 | |
| MRSN Mersana Therapeutics | Upgrades: Buy | $9 | $1.86 | +383.87% | 3 | Feb 29, 2024 | |
| EXEL Exelixis | Reiterates: Buy | $32 | $22.15 | +44.47% | 3 | Sep 13, 2023 | |
| IGMS IGM Biosciences | Reiterates: Buy | $25 | $6.40 | +290.63% | 5 | Sep 6, 2023 | |
| HOOK HOOKIPA Pharma | Reiterates: Buy | $4 | $0.58 | +587.76% | 4 | Sep 6, 2023 | |
| ACET Adicet Bio | Reiterates: Buy | $27 | $1.10 | +2,354.55% | 2 | Sep 6, 2023 | |
| AUTL Autolus Therapeutics | Maintains: Buy | $6 → $9 | $3.38 | +166.27% | 3 | Aug 17, 2023 | |
| TIL Instil Bio | Reinstates: Hold | $120 | $10.04 | +1,095.22% | 1 | Apr 5, 2023 | |
| CELU Celularity | Maintains: Hold | $100 → $60 | $3.11 | +1,832.37% | 3 | Aug 23, 2022 | |
| NXTC NextCure | Maintains: Buy | $19 → $15 | $1.50 | +900.00% | 4 | Aug 23, 2022 |
Arcus Biosciences
Jun 24, 2024
Maintains: Buy
Price Target: $50 → $44
Current: $14.65
Upside: +200.34%
Arcellx
Jun 18, 2024
Maintains: Buy
Price Target: $87
Current: $53.25
Upside: +63.38%
Legend Biotech
Jun 17, 2024
Initiates: Buy
Price Target: $88
Current: $44.74
Upside: +96.69%
Genmab
Jun 4, 2024
Maintains: Buy
Price Target: $50 → $53
Current: $24.90
Upside: +112.85%
Merus
Jun 4, 2024
Maintains: Buy
Price Target: $69 → $88
Current: $53.09
Upside: +65.76%
Compugen
May 21, 2024
Maintains: Buy
Price Target: $5 → $4
Current: $1.69
Upside: +136.69%
Caribou Biosciences
May 16, 2024
Maintains: Buy
Price Target: $19
Current: $1.60
Upside: +1,087.50%
CARGO Therapeutics
May 16, 2024
Reiterates: Buy
Price Target: $34 → $32
Current: $15.83
Upside: +102.15%
Allogene Therapeutics
May 15, 2024
Maintains: Buy
Price Target: $17
Current: $2.16
Upside: +687.04%
Sutro Biopharma
Apr 3, 2024
Maintains: Buy
Price Target: $25 → $18
Current: $2.96
Upside: +508.11%
Iovance Biotherapeutics
Mar 7, 2024
Maintains: Buy
Price Target: $17 → $26
Current: $7.73
Upside: +236.35%
Mersana Therapeutics
Feb 29, 2024
Upgrades: Buy
Price Target: $9
Current: $1.86
Upside: +383.87%
Exelixis
Sep 13, 2023
Reiterates: Buy
Price Target: $32
Current: $22.15
Upside: +44.47%
IGM Biosciences
Sep 6, 2023
Reiterates: Buy
Price Target: $25
Current: $6.40
Upside: +290.63%
HOOKIPA Pharma
Sep 6, 2023
Reiterates: Buy
Price Target: $4
Current: $0.58
Upside: +587.76%
Adicet Bio
Sep 6, 2023
Reiterates: Buy
Price Target: $27
Current: $1.10
Upside: +2,354.55%
Autolus Therapeutics
Aug 17, 2023
Maintains: Buy
Price Target: $6 → $9
Current: $3.38
Upside: +166.27%
Instil Bio
Apr 5, 2023
Reinstates: Hold
Price Target: $120
Current: $10.04
Upside: +1,095.22%
Celularity
Aug 23, 2022
Maintains: Hold
Price Target: $100 → $60
Current: $3.11
Upside: +1,832.37%
NextCure
Aug 23, 2022
Maintains: Buy
Price Target: $19 → $15
Current: $1.50
Upside: +900.00%